Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03152929Phase 3Terminated
Phase 3, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Corewell Health. Primary endpoints: Intraoperative Narcotic Use, Post Anesthesia Care Unit Narcotic Use and 1 more. Started Mar 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03152929.